DR. JONATHAN TILL, MD
Medical Practice at Electric Rd, Roanoke, VA
License number
Virginia 0101040106
Category
Medical Practice
Type
Ophthalmology
Address
Address
3090 Electric Rd SUITE B, Roanoke, VA 24018
Phone
(540) 772-3978
(540) 400-0001 (Fax)
(540) 400-0001 (Fax)
Professional information
Dr. Jonathan S Till, Roanoke VA - MD (Doctor of Medicine)
Address:
Southwest Virginia Eye Center
3090 Electric Rd STE B, Roanoke 24018
(540) 772-3978 (Phone), (540) 400-0061 (Fax)
3090 Electric Rd STE B, Roanoke 24018
(540) 772-3978 (Phone), (540) 400-0061 (Fax)
Hospitals:
Southwest Virginia Eye Center
3090 Electric Rd STE B, Roanoke 24018
3090 Electric Rd STE B, Roanoke 24018
Philosophy:
Personal and individual care provided with the greatest of integrity in a clean modern facility.
Education:
Medical Schools
Emory University School Of Medicine
Graduated: 1982
Emory University School Of Medicine
Graduated: 1982
Owner At Southwest Virginia Eye Center
Location:
Roanoke, Virginia Area
Industry:
Medical Practice
Presbyopia Treatment By Lens Alteration
US Patent:
8147816, Apr 3, 2012
Filed:
Nov 28, 2007
Appl. No.:
11/946659
Inventors:
Jonathan S. Till - Roanoke VA, US
Ronald D. Blum - Roanoke VA, US
William R. Burns - North Richland Hills TX, US
Ronald D. Blum - Roanoke VA, US
William R. Burns - North Richland Hills TX, US
Assignee:
Encore Health, LLC - Roanoke VA
International Classification:
A61K 31/74
US Classification:
424 7804
Abstract:
Embodiments of the present invention relate to methods and pharmacological or biological compositions to treat presbyopia in the human eye. According to the embodiments, pharmacological or biological compositions may be applied to or injected into an eye to effect a change in the accommodative ability of the eye by the breaking and reduction of lenticular bonds in the eye that may be responsible for presbyopia. The compositions may be applied in an inactive state and subsequently be activated to achieve a therapeutic effect. The application of energy may be used to either break the oxidized lenticular bonds and/or to activate one or more of the pharmacological or biological agents. The energy may be used in a focus treatment pattern to affect a change in the refractive characteristics of the eye and thereby reduce inherent optical distortions.
Presbyopia Treatment By Lens Alteration
US Patent:
2005011, May 26, 2005
Filed:
Oct 22, 2004
Appl. No.:
10/969868
Inventors:
Jonathan Till - Roanoke VA, US
Ronald Blum - Roanoke VA, US
Ronald Blum - Roanoke VA, US
International Classification:
A61K038/43, A61F002/14
US Classification:
424094100, 424427000
Abstract:
Embodiments of the present invention relate to methods and pharmacological compositions to treat presbyopia in the human eye. According to the embodiments, pharmacological compositions may be applied to an eye to effect a change in the accommodative ability of the eye by the breaking and reduction of lenticular bonds in the eye that may be responsible for presbyopia. The compositions may be applied in an inactive state and subsequently be activated to achieve a therapeutic effect.
Presbyopia Treatment By Lens Alteration
US Patent:
2011013, Jun 9, 2011
Filed:
Feb 16, 2011
Appl. No.:
13/028766
Inventors:
Jonathan S. Till - Roanoke VA, US
Ronald D. Blum - Roanoke VA, US
Ronald D. Blum - Roanoke VA, US
Assignee:
Encore Health, LLC - Roanoke VA
International Classification:
A61N 1/30, A61K 38/44, A61K 38/45, A61K 38/51, A61K 38/06, A61K 31/255, A61P 27/02
US Classification:
424 944, 604 20, 424 945, 514 208, 514517
Abstract:
This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.